Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Thieblemont

A FDG-PET Driven Consolidation Strategy in Diffuse Large B-Cell Lymphoma: Final Results of a Randomized Phase II Study

Blood

English

Targeting of B-Cell Receptor Signalling in B-Cell Malignancies

Journal of Internal Medicine

Internal Medicine

2017

English

Recovery of Central Memory and Naive Peripheral T Cells in Follicular Lymphoma Patients Receiving Rituximab-Chemotherapy Based Regimen

Scientific Reports

Multidisciplinary

2019

English

LOW NK CELL COUNT AT DIAGNOSIS IS ASSOCIATED WITH SHORTER PFS IN ELDERLY PATIENTS WITH DLBCL TREATED WITH RCHOP AND RANDOMIZED FOR LENALIDOMIDE MAINTENANCE: A LYSA STUDY

Hematological Oncology

English

Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free and Overall Survival in Mantle Cell Lymphoma

Hematological Oncology

English

Refinement of Mum1 Expression Threshold for Double Positive Cd10+ Mum1+ Diffuse Large B Cell Lymphoma Allows a Better Cell of Origin Classification for GCB Subtype

Hematological Oncology

English

Preliminary Results of Earlier Steroid Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients With Relapsed/Refractory Large B Cell Lymphoma

Hematological Oncology

English

Post Hoc Analyses of Patients With Relapsed/Refractory Marginal Zone Lymphoma Who Received Lenalidomide Plus Rituximab (R2 ) vs Rituximab/Placebo (Augment)

Hematological Oncology

English

Elara: A Phase 2 Trial Investigating the Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory/Relapsed Follicular Lymphoma

Hematological Oncology

English

Multi-Omics Landscape of Splenic Marginal Zone Lymphoma (Smzl) - Interim Analysis of Ielsg46 Study

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Thieblemont

A FDG-PET Driven Consolidation Strategy in Diffuse Large B-Cell Lymphoma: Final Results of a Randomized Phase II Study

Targeting of B-Cell Receptor Signalling in B-Cell Malignancies

Recovery of Central Memory and Naive Peripheral T Cells in Follicular Lymphoma Patients Receiving Rituximab-Chemotherapy Based Regimen

LOW NK CELL COUNT AT DIAGNOSIS IS ASSOCIATED WITH SHORTER PFS IN ELDERLY PATIENTS WITH DLBCL TREATED WITH RCHOP AND RANDOMIZED FOR LENALIDOMIDE MAINTENANCE: A LYSA STUDY

Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free and Overall Survival in Mantle Cell Lymphoma

Refinement of Mum1 Expression Threshold for Double Positive Cd10+ Mum1+ Diffuse Large B Cell Lymphoma Allows a Better Cell of Origin Classification for GCB Subtype

Preliminary Results of Earlier Steroid Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients With Relapsed/Refractory Large B Cell Lymphoma

Post Hoc Analyses of Patients With Relapsed/Refractory Marginal Zone Lymphoma Who Received Lenalidomide Plus Rituximab (R2 ) vs Rituximab/Placebo (Augment)

Elara: A Phase 2 Trial Investigating the Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory/Relapsed Follicular Lymphoma

Multi-Omics Landscape of Splenic Marginal Zone Lymphoma (Smzl) - Interim Analysis of Ielsg46 Study